DOCSLIB.ORG

ICD-10-CM to ICD-10 Based on FY2016 ICD-10-CM Codes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ICD-10-CM to ICD-10 Based on FY2016 ICD-10-CM Codes ICD-10-CM to ICD-10 Based on FY2017 ICD-10-CM codes Category and subcategory codes are shaded in grey and marked with an ^ Cells shaded in pink and marked with an *indicate the preferred code when a single code maps to multiple codes (see Introduction) Reportable Neoplasms ICD-10-CM ICD-10 Chapter II (Neoplasms) ICD-10-CM Term Chapter II (Neoplasms) ICD-10 Term Type of Code Category Category CATEGORY ^C00 MALIGNANT NEOPLASM OF LIP ^C00 MALIGNANT NEOPLASM OF LIP REPORTABLE C00.0 Malignant neoplasm of external upper lip C00.0 Malignant neoplasm of external upper lip REPORTABLE C00.1 Malignant neoplasm of external lower lip C00.1 Malignant neoplasm of external lower lip REPORTABLE C00.2 Malignant neoplasm of external lip, unspecified C00.2 Malignant neoplasm of external lip, unspecified REPORTABLE C00.3 Malignant neoplasm of upper lip, inner aspect C00.3 Malignant neoplasm of upper lip, inner aspect REPORTABLE C00.4 Malignant neoplasm of lower lip, inner aspect C00.4 Malignant neoplasm of lower lip, inner aspect REPORTABLE C00.5 Malignant neoplasm of lip, unspecified, inner aspect C00.5 Malignant neoplasm of lip, unspecified, inner aspect REPORTABLE C00.6 Malignant neoplasm of commissure of lip, unspecified C00.6 Malignant neoplasm of commissure of lip REPORTABLE C00.8 Malignant neoplasm of overlapping sites of lip C00.8 Malignant neoplasm of overlapping sites of lip REPORTABLE C00.9 Malignant neoplasm of lip, unspecified C00.9 Malignant neoplasm of lip, unspecified REPORTABLE ^C01 MALIGNANT NEOPLASM OF BASE OF TONGUE ^C01 MALIGNANT NEOPLASM OF BASE OF TONGUE CATEGORY ^C02 MALIGNANT NEOPLASM OF OTHER AND ^C02 MALIGNANT NEOPLASM OF OTHER AND UNSPECIFIED UNSPECIFIED PARTS OF TONGUE PARTS OF TONGUE REPORTABLE C02.0 Malignant neoplasm of dorsal surface of tongue C02.0 Malignant neoplasm of dorsal surface of tongue REPORTABLE C02.1 Malignant neoplasm of border of tongue C02.1 Malignant neoplasm of border of tongue REPORTABLE C02.2 Malignant neoplasm of ventral surface of tongue C02.2 Malignant neoplasm of ventral surface of tongue REPORTABLE C02.3 Malignant neoplasm of anterior two-thirds of tongue, C02.3 Malignant neoplasm of anterior two-thirds of tongue, part part unspecified unspecified REPORTABLE C02.4 Malignant neoplasm of lingual tonsil C02.4 Malignant neoplasm of lingual tonsil REPORTABLE C02.8 Malignant neoplasm of overlapping sites of tongue C02.8 Malignant neoplasm of overlapping sites of tongue REPORTABLE C02.9 Malignant neoplasm of tongue, unspecified C02.9 Malignant neoplasm of tongue, unspecified CATEGORY ^C03 MALIGNANT NEOPLASM OF GUM ^C03 MALIGNANT NEOPLASM OF GUM REPORTABLE C03.0 Malignant neoplasm of upper gum C03.0 Malignant neoplasm of upper gum REPORTABLE C03.1 Malignant neoplasm of lower gum C03.1 Malignant neoplasm of lower gum REPORTABLE C03.9 Malignant neoplasm of gum, unspecified C03.9 Malignant neoplasm of gum, unspecified CATEGORY ^C04 MALIGNANT NEOPLASM OF FLOOR OF MOUTH ^C04 MALIGNANT NEOPLASM OF FLOOR OF MOUTH REPORTABLE C04.0 Malignant neoplasm of anterior floor of mouth C04.0 Malignant neoplasm of anterior floor of mouth REPORTABLE C04.1 Malignant neoplasm of lateral floor of mouth C04.1 Malignant neoplasm of lateral floor of mouth ICD-10-CM to ICD-10 Based on FY2017 ICD-10-CM codes ICD-10-CM ICD-10 Chapter II (Neoplasms) ICD-10-CM Term Chapter II (Neoplasms) ICD-10 Term Type of Code Category Category REPORTABLE C04.8 Malignant neoplasm of overlapping sites of floor of C04.8 Malignant neoplasm of overlapping sites of floor of mouth mouth REPORTABLE C04.9 Malignant neoplasm of floor of mouth, unspecified C04.9 Malignant neoplasm of floor of mouth, unspecified CATEGORY ^C05 MALIGNANT NEOPLASM OF PALATE ^C05 MALIGNANT NEOPLASM OF PALATE REPORTABLE C05.0 Malignant neoplasm of hard palate C05.0 Malignant neoplasm of hard palate REPORTABLE C05.1 Malignant neoplasm of soft palate C05.1 Malignant neoplasm of soft palate REPORTABLE C05.2 Malignant neoplasm of uvula C05.2 Malignant neoplasm of uvula REPORTABLE C05.8 Malignant neoplasm of overlapping sites of palate C05.8 Malignant neoplasm of overlapping sites of palate REPORTABLE C05.9 Malignant neoplasm of palate, unspecified C05.9 Malignant neoplasm of palate, unspecified CATEGORY ^C06 MALIGNANT NEOPLASM OF OTHER AND ^C06 MALIGNANT NEOPLASM OF OTHER AND UNSPECIFIED UNSPECIFIED PARTS OF MOUTH PARTS OF MOUTH REPORTABLE C06.0 Malignant neoplasm of cheek mucosa C06.0 Malignant neoplasm of cheek mucosa REPORTABLE C06.1 Malignant neoplasm of vestibule of mouth C06.1 Malignant neoplasm of vestibule of mouth REPORTABLE C06.2 Malignant neoplasm of retromolar area C06.2 Malignant neoplasm of retromolar area SUBCATEGORY ^C06.8 Malignant neoplasm of overlapping sites of other C06.8 Malignant neoplasm of overlapping sites of other and unspecified parts of mouth unspecified parts of mouth REPORTABLE C06.80 Malignant neoplasm of overlapping sites of C06.8 Malignant neoplasm of overlapping sites of other and unspecified parts of mouth unspecified parts of mouth REPORTABLE C06.89 Malignant neoplasm of overlapping sites of other parts C06.8 Malignant neoplasm of overlapping sites of other and of mouth unspecified parts of mouth REPORTABLE C06.9 Malignant neoplasm of mouth, unspecified C06.9 Malignant neoplasm of mouth, unspecified REPORTABLE ^C07 MALIGNANT NEOPLASM OF PAROTID GLAND ^C07 MALIGNANT NEOPLASM OF PAROTID GLAND CATEGORY ^C08 MALIGNANT NEOPLASM OF OTHER AND ^C08 MALIGNANT NEOPLASM OF OTHER AND UNSPECIFIED UNSPECIFIED MAJOR SALIVARY GLANDS MAJOR SALIVARY GLANDS REPORTABLE C08.0 Malignant neoplasm of submandibular gland C08.0 Malignant neoplasm of submandibular gland REPORTABLE C08.1 Malignant neoplasm of sublingual gland C08.1 Malignant neoplasm of sublingual gland REPORTABLE C08.9 Malignant neoplasm of major salivary gland, *C08.9 Malignant neoplasm of major salivary gland, unspecified unspecified C08.8 Overlapping lesion of major salivary glands CATEGORY ^C09 MALIGNANT NEOPLASM OF TONSIL ^C09 MALIGNANT NEOPLASM OF TONSIL REPORTABLE C09.0 Malignant neoplasm of tonsillar fossa C09.0 Malignant neoplasm of tonsillar fossa REPORTABLE C09.1 Malignant neoplasm of tonsillar pillar (anterior) C09.1 Malignant neoplasm of tonsillar pillar (anterior) (posterior) (posterior) REPORTABLE C09.8 Malignant neoplasm of overlapping sites of tonsil C09.8 Malignant neoplasm of overlapping sites of tonsil ICD-10-CM to ICD-10 Based on FY2017 ICD-10-CM codes ICD-10-CM ICD-10 Chapter II (Neoplasms) ICD-10-CM Term Chapter II (Neoplasms) ICD-10 Term Type of Code Category Category REPORTABLE C09.9 Malignant neoplasm of tonsil, unspecified C09.9 Malignant neoplasm of tonsil, unspecified CATEGORY ^C10 MALIGNANT NEOPLASM OF OROPHARYNX ^C10 MALIGNANT NEOPLASM OF OROPHARYNX REPORTABLE C10.0 Malignant neoplasm of vallecula C10.0 Malignant neoplasm of vallecula REPORTABLE C10.1 Malignant neoplasm of anterior surface of epiglottis C10.1 Malignant neoplasm of anterior surface of epiglottis REPORTABLE C10.2 Malignant neoplasm of lateral wall of oropharynx C10.2 Malignant neoplasm of lateral wall of oropharynx REPORTABLE C10.3 Malignant neoplasm of posterior wall of oropharynx C10.3 Malignant neoplasm of posterior wall of oropharynx REPORTABLE C10.4 Malignant neoplasm of branchial cleft C10.4 Malignant neoplasm of branchial cleft REPORTABLE C10.8 Malignant neoplasm of overlapping sites of C10.8 Malignant neoplasm of overlapping sites of oropharynx oropharynx REPORTABLE C10.9 Malignant neoplasm of oropharynx, unspecified C10.9 Malignant neoplasm of oropharynx, unspecified CATEGORY ^C11 MALIGNANT NEOPLASM OF NASOPHARYNX ^C11 MALIGNANT NEOPLASM OF NASOPHARYNX REPORTABL C11.0 Malignant neoplasm of superior wall of nasopharynx C11.0 Malignant neoplasm of superior wall of nasopharynx REPORTABLE C11.1 Malignant neoplasm of posterior wall of nasopharynx C11.1 Malignant neoplasm of posterior wall of nasopharynx REPORTABLE C11.2 Malignant neoplasm of lateral wall of nasopharynx C11.2 Malignant neoplasm of lateral wall of nasopharynx REPORTABLE C11.3 Malignant neoplasm of anterior wall of nasopharynx C11.3 Malignant neoplasm of anterior wall of nasopharynx REPORTABLE C11.8 Malignant neoplasm of overlapping sites of C11.8 Malignant neoplasm of overlapping sites of nasopharynx nasopharynx REPORTABLE C11.9 Malignant neoplasm of nasopharynx, unspecified C11.9 Malignant neoplasm of nasopharynx, unspecified REPORTABLE ^C12 MALIGNANT NEOPLASM OF PYRIFORM SINUS ^C12 MALIGNANT NEOPLASM OF PYRIFORM SINUS CATEGORY ^C13 MALIGNANT NEOPLASM OF HYPOPHARYNX ^C13 MALIGNANT NEOPLASM OF HYPOPHARYNX REPORTABLE C13.0 Malignant neoplasm of postcricoid region C13.0 Malignant neoplasm of postcricoid region REPORTABLE C13.1 Malignant neoplasm aryepiglottic fold, C13.1 Malignant neoplasm aryepiglottic fold, hypopharyngeal hypopharyngeal aspect aspect REPORTABLE C13.2 Malignant neoplasm of posterior wall of hypopharynx C13.2 Malignant neoplasm of posterior wall of hypopharynx REPORTABLE C13.8 Malignant neoplasm of overlapping sites of C13.8 Malignant neoplasm of overlapping sites of hypopharynx hypopharynx REPORTABLE C13.9 Malignant neoplasm of hypopharynx, unspecified C13.9 Malignant neoplasm of hypopharynx, unspecified CATEGORY ^C14 MALIGNANT NEOPLASM OF OTHER AND ILL-DEFINED ^C14 MALIGNANT NEOPLASM OF OTHER AND ILL-DEFINED SITES IN THE LIP, ORAL CAVITY AND PHARYNX SITES IN THE LIP, ORAL CAVITY AND PHARYNX REPORTABLE C14.0 Malignant neoplasm of pharynx, unspecified C14.0 Malignant neoplasm of pharynx, unspecified REPORTABLE C14.2 Malignant neoplasm of Waldeyer's ring C14.2 Malignant neoplasm of Waldeyer's ring REPORTABLE C14.8 Malignant
Load more

Recommended publications
  • The Clinical Management of Chronic Myelomonocytic Leukemia Eric Padron, MD, Rami Komrokji, and Alan F
    The Clinical Management of Chronic Myelomonocytic Leukemia Eric Padron, MD, Rami Komrokji, and Alan F. List, MD Dr Padron is an assistant member, Dr Abstract: Chronic myelomonocytic leukemia (CMML) is an Komrokji is an associate member, and Dr aggressive malignancy characterized by peripheral monocytosis List is a senior member in the Department and ineffective hematopoiesis. It has been historically classified of Malignant Hematology at the H. Lee as a subtype of the myelodysplastic syndromes (MDSs) but was Moffitt Cancer Center & Research Institute in Tampa, Florida. recently demonstrated to be a distinct entity with a distinct natu- ral history. Nonetheless, clinical practice guidelines for CMML Address correspondence to: have been inferred from studies designed for MDSs. It is impera- Eric Padron, MD tive that clinicians understand which elements of MDS clinical Assistant Member practice are translatable to CMML, including which evidence has Malignant Hematology been generated from CMML-specific studies and which has not. H. Lee Moffitt Cancer Center & Research Institute This allows for an evidence-based approach to the treatment of 12902 Magnolia Drive CMML and identifies knowledge gaps in need of further study in Tampa, Florida 33612 a disease-specific manner. This review discusses the diagnosis, E-mail: [email protected] prognosis, and treatment of CMML, with the task of divorcing aspects of MDS practice that have not been demonstrated to be applicable to CMML and merging those that have been shown to be clinically similar. Introduction Chronic myelomonocytic leukemia (CMML) is a clonal hemato- logic malignancy characterized by absolute peripheral monocytosis, ineffective hematopoiesis, and an increased risk of transformation to acute myeloid leukemia.
    [Show full text]
  • Human Anatomy As Related to Tumor Formation Book Four
    SEER Program Self Instructional Manual for Cancer Registrars Human Anatomy as Related to Tumor Formation Book Four Second Edition U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutesof Health SEER PROGRAM SELF-INSTRUCTIONAL MANUAL FOR CANCER REGISTRARS Book 4 - Human Anatomy as Related to Tumor Formation Second Edition Prepared by: SEER Program Cancer Statistics Branch National Cancer Institute Editor in Chief: Evelyn M. Shambaugh, M.A., CTR Cancer Statistics Branch National Cancer Institute Assisted by Self-Instructional Manual Committee: Dr. Robert F. Ryan, Emeritus Professor of Surgery Tulane University School of Medicine New Orleans, Louisiana Mildred A. Weiss Los Angeles, California Mary A. Kruse Bethesda, Maryland Jean Cicero, ART, CTR Health Data Systems Professional Services Riverdale, Maryland Pat Kenny Medical Illustrator for Division of Research Services National Institutes of Health CONTENTS BOOK 4: HUMAN ANATOMY AS RELATED TO TUMOR FORMATION Page Section A--Objectives and Content of Book 4 ............................... 1 Section B--Terms Used to Indicate Body Location and Position .................. 5 Section C--The Integumentary System ..................................... 19 Section D--The Lymphatic System ....................................... 51 Section E--The Cardiovascular System ..................................... 97 Section F--The Respiratory System ....................................... 129 Section G--The Digestive System ......................................... 163 Section
    [Show full text]
  • Head and Neck Specimens
    Head and Neck Specimens DEFINITIONS AND GENERAL COMMENTS: All specimens, even of the same type, are unique, and this is particularly true for Head and Neck specimens. Thus, while this outline is meant to provide a guide to grossing the common head and neck specimens at UAB, it is not all inclusive and will not capture every scenario. Thus, careful assessment of each specimen with some modifications of what follows below may be needed on a case by case basis. When in doubt always consult with a PA, Chief/Senior Resident and/or the Head and Neck Pathologist on service. Specimen-derived margin: A margin taken directly from the main specimen-either a shave or radial. Tumor bed margin: A piece of tissue taken from the operative bed after the main specimen has been resected. This entire piece of tissue may represent the margin, or it could also be specifically oriented-check specimen label/requisition for any further orientation. Margin status as determined from specimen-derived margins has been shown to better predict local recurrence as compared to tumor bed margins (Surgical Pathology Clinics. 2017; 10: 1-14). At UAB, both methods are employed. Note to grosser: However, even if a surgeon submits tumor bed margins separately, the grosser must still sample the specimen margins. Figure 1: Shave vs radial (perpendicular) margin: Figure adapted from Surgical Pathology Clinics. 2017; 10: 1-14): Red lines: radial section (perpendicular) of margin Blue line: Shave of margin Comparison of shave and radial margins (Table 1 from Chiosea SI. Intraoperative Margin Assessment in Early Oral Squamous Cell Carcinoma.
    [Show full text]
  • The 2016 Revision to the World Health Organization Classification of Myeloid Neoplasms and Acute Leukemia
    From www.bloodjournal.org by guest on January 9, 2019. For personal use only. Review Series THE UPDATED WHO CLASSIFICATION OF HEMATOLOGICAL MALIGNANCIES The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Daniel A. Arber,1 Attilio Orazi,2 Robert Hasserjian,3 J¨urgen Thiele,4 Michael J. Borowitz,5 Michelle M. Le Beau,6 Clara D. Bloomfield,7 Mario Cazzola,8 and James W. Vardiman9 1Department of Pathology, Stanford University, Stanford, CA; 2Department of Pathology, Weill Cornell Medical College, New York, NY; 3Department of Pathology, Massachusetts General Hospital, Boston, MA; 4Institute of Pathology, University of Cologne, Cologne, Germany; 5Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD; 6Section of Hematology/Oncology, University of Chicago, Chicago, IL; 7Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH; 8Department of Molecular Medicine, University of Pavia, and Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; and 9Department of Pathology, University of Chicago, Chicago, IL The World Health Organization (WHO) the prognostic relevance of entities cur- The 2016 edition represents a revision classification of tumors of the hemato- rently included in the WHO classification of the prior classification rather than poietic and lymphoid tissues was last and that also suggest new entities that an entirely new classification and at- updated in 2008. Since then, there have should be added. Therefore, there is a tempts to incorporate new clinical, prog- been numerous advances in the identifi- clear need for a revision to the current nostic, morphologic, immunophenotypic, cation of unique biomarkers associated classification.
    [Show full text]
  • Head and Neck: Summary Stage 2018 Coding Manual V2.0
    HEAD AND NECK DEFINITION OF ANATOMIC SITES WITHIN THE HEAD AND NECK Note: Not all sites in the lip, oral cavity, pharynx and salivary glands are listed below. All sites to which a Summary Stage chapter applies are listed at the beginning of the chapter. LIP, ORAL CAVITY and PHARYNX The oral cavity extends from the skin-vermilion junction of the lips to the junction of the hard and soft palate above and to the line of circumvallate papillae below. LIP AND ORAL CAVITY Site ICD-O Description LIPS C00_ Vermilion surface, mucosal lip, labial (mucosa) upper and lower, form the upper and lower anterior wall of the oral cavity. They consist of an exposed surface of modified epidermis beginning at the junction of the vermilion border with the skin and including only the vermilion surface or that portion of the lip that meets the opposing lip. The lips extend from commissure to commissure. COMMISSURE C006 (corner of mouth) is the point of union of upper and lower lips and is part of the lip OF LIP ANTERIOR C02_ (mobile or oral tongue) consists of the freely movable portion of the tongue which 2/3 OF extends anteriorly from the line of circumvallate papillae to the root of the tongue at the TONGUE junction of the floor of the mouth. It is composed of four areas: tip, lateral borders, dorsum, and undersurface or ventral surface (non-villous surface). UPPER GUM C030 (upper alveolar ridge) is the covering mucosa of the alveolar process of the maxilla, extending from the line of attachment of mucosa in the upper gingival buccal gutter to the junction of the hard palate.
    [Show full text]
  • A Retrospective Comparison of Tumor Recurrence and Patient Survival After
    Yale University EliScholar – A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 1987 A retrospective comparison of tumor recurrence and patient survival after treatment with preoperative radiation therapy and surgery, or surgery and postoperative radiation therapy for squamous cell carcinoma of the pyriform sinus and hypopharynx Jesse George Wardlow Jr. Yale University Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl Recommended Citation Wardlow, Jesse George Jr., "A retrospective comparison of tumor recurrence and patient survival after treatment with preoperative radiation therapy and surgery, or surgery and postoperative radiation therapy for squamous cell carcinoma of the pyriform sinus and hypopharynx" (1987). Yale Medicine Thesis Digital Library. 3284. http://elischolar.library.yale.edu/ymtdl/3284 This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital Platform for Scholarly Publishing at Yale. For more information, please contact [email protected]. A RETROSPECTIVE COMPARISON OF Permission for photocopying or microfilming of purpose of individual scholarly consultation or reference is hereby granted by the author. This permission is not to be interpreted as affecting publication of this work, or otherwise placing
    [Show full text]
  • Oligomonocytic Chronic Myelomonocytic Leukemia
    Modern Pathology (2017) 30, 1213–1222 © 2017 USCAP, Inc All rights reserved 0893-3952/17 $32.00 1213 Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia Julia T Geyer1, Wayne Tam1, Yen-Chun Liu1, Zhengming Chen2, Sa A Wang3, Carlos Bueso-Ramos3, Jean Oak4, Daniel A Arber5, Eric Hsi6, Heesun J Rogers6, Katherine Levinson7, Adam Bagg7, Duane C Hassane1, Robert P Hasserjian8 and Attilio Orazi1 1Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA; 2Division of Biostatistics and Epidemiology, Department of Healthcare Policy & Research, Weill Cornell Medical College, New York, NY, USA; 3Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA; 4Department of Pathology, Stanford University, Stanford, CA, USA; 5Department of Pathology, University of Chicago, Chicago, IL, USA; 6Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA; 7Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA and 8Department of Pathology, Massachusetts General Hospital, Boston, MA, USA Chronic myelomonocytic leukemia is characterized by persistent absolute monocytosis (≥1×109/l) in the peripheral blood and dysplasia in ≥ 1 lineages. In the absence of dysplasia, an acquired clonal genetic abnormality is required or causes for reactive monocytosis have to be excluded.
    [Show full text]
  • 190.18 - Serum Iron Studies
    Medicare National Coverage Determinations (NCD) Coding Policy Manual and Change Report (ICD-10-CM) 190.18 - Serum Iron Studies HCPCS Codes (Alphanumeric, CPT AMA) Code Description 82728 Ferritin 83540 Iron 83550 Iron Binding capacity 84466 Transferrin ICD-10-CM Codes Covered by Medicare Program The ICD-10-CM codes in the table below can be viewed on CMS’ website as part of Downloads: Lab Code List, at http://www.cms.gov/Medicare/Coverage/CoverageGenInfo/LabNCDsICD10.html Code Description A01.00 Typhoid fever, unspecified A01.01 Typhoid meningitis A01.02 Typhoid fever with heart involvement A01.03 Typhoid pneumonia A01.04 Typhoid arthritis A01.05 Typhoid osteomyelitis A01.09 Typhoid fever with other complications A01.1 Paratyphoid fever A A01.2 Paratyphoid fever B A01.3 Paratyphoid fever C A01.4 Paratyphoid fever, unspecified A02.0 Salmonella enteritis A02.1 Salmonella sepsis A02.20 Localized salmonella infection, unspecified NCD 190.18 January 2021 Changes ICD-10-CM Version – Red Fu Associates, Ltd. January 2021 1 Medicare National Coverage Determinations (NCD) Coding Policy Manual and Change Report (ICD-10-CM) Code Description A02.21 Salmonella meningitis A02.22 Salmonella pneumonia A02.23 Salmonella arthritis A02.24 Salmonella osteomyelitis A02.25 Salmonella pyelonephritis A02.29 Salmonella with other localized infection A02.8 Other specified salmonella infections A02.9 Salmonella infection, unspecified A04.0 Enteropathogenic Escherichia coli infection A04.1 Enterotoxigenic Escherichia coli infection A04.2 Enteroinvasive Escherichia
    [Show full text]
  • Pitfalls in the Staging of Cancer of the Oropharyngeal Squamous Cell Carcinoma
    Pitfalls in the Staging of Cancer of the Oropharyngeal Squamous Cell Carcinoma Amanda Corey, MD KEYWORDS Oropharyngeal squamous cell carcinoma Oropharynx Human papilloma virus Transoral robotic surgery KEY POINTS Oropharyngeal squamous cell carcinoma (OPSCC) has a dichotomous nature with 1 subset of the disease associated with tobacco and alcohol use and the other having proven association with human papilloma virus infection. Imaging plays an important role in the staging and surveillance of OPSCC. A detailed knowledge of the anatomy and pitfalls is critical. This article reviews the detailed anatomy of the oropharynx and epidemiology of OPSCC, along with its staging, patterns of spread, and treatment. Anatomic extent of disease is central to deter- tissue, constrictor muscles, and fascia. The over- mining stage and prognosis, and optimizing treat- whelming tumor pathology is squamous cell carci- ment planning for head and neck squamous cell noma (SCC), arising from the mucosal surface. carcinoma (HNSCC). The anatomic boundaries of As the OP contents include lymphoid tissue and the oropharynx (OP) are the soft palate superiorly, minor salivary glands, lymphoma and nonsqua- hyoid bone, and vallecula inferiorly, and circumvel- mous cell tumors of salivary origin can occur.2 late papilla anteriorly. The OP communicates with In understanding spread of disease from the OP, the nasopharynx superiorly and the hypopharynx it is helpful to remember the fascial boundaries and supraglottic larynx inferiorly, and is continuous subtending the OP, to recall the relationship of with the oral cavity anteriorly. The palatoglossus the pharyngeal constrictor muscles with the ptery- muscle forms the anterior tonsillar pillar, and the gomandibular raphe and the deep cervical fascia, palatopharyngeus muscle forms the posterior and to be aware of the adjacent spaces and struc- tonsillar pillar.
    [Show full text]
  • Chronic Myelomonocytic Leukemia with Der(9)T(1;9)(Q11;Q34) As a Sole Abnormality
    Available online at www.annclinlabsci.org Annals of Clinical & Laboratory Science, vol. 39, no. 3, 2009 307 Case Report and Review of the Literature: Chronic Myelomonocytic Leukemia with der(9)t(1;9)(q11;q34) as a Sole Abnormality Borum Suh,1 Tae Sung Park,1* Jin Seok Kim,2 Jaewoo Song,1 Juwon Kim,1 Jong-Ha Yoo,1,3 and Jong Rak Choi1 Departments of 1Laboratory Medicine and 2Internal Medicine, Yonsei University College of Medicine, Seoul, Korea; 3Department of Laboratory Medicine, National Health Insurance Corporation Ilsan Hospital, Goyang-si, Kyonggi-do, Korea Abstract. The chromosomal abnormality der(9)t(1;9)(q11;q34) is a rare occurrence in patients with hematologic malignancies. As far as we know, only 3 cases of acute myeloid leukemia, 1 case of polycythemia vera, and 1 case of multiple myeloma with this derivative chromosome have been reported in the literature. Here we report the first case of der(9)t(1;9)(q11;q34) in a patient with chronic myelomonocytic leukemia (CMML). A 45-yr-old man was brought to our hospital for evaluation of pancytopenia and monocytosis. The patient’s persistent monocytosis in peripheral blood and his bone marrow findings were consistent with the diagnosis of CMML. Chromosome study results repeatedly showed 46,XY,der(9)t(1;9)(q11;q34). In addition, the BCR/ABL fluorescent in situ hybridization (FISH) pattern of the interphase cells was interpreted as: “nuc ish(ABL, BCR) x 2[292/300],” consistent with the normal signal patterns found in 97% of the nuclei examined. For further evaluation, multi-color FISH (mFISH) analysis was performed and it showed the distinct unbalanced derivative chromosome der(9)t(1;9)(q11;q34) in 5 metaphase cells analyzed.
    [Show full text]
  • And Some Additional ICD10 Diagnosis Codes That Support Medical Necessity to the Final Policy
    April 11, 2018 Virginia Muir LCD Comments P.O. Box 7108 Indianapolis, IN 46207 [email protected] RE: Molecular Pathology Procedures Dear Ms. Muir, Thank you for the opportunity to review and comment on National Government Services’ proposed coverage policy for Molecular Pathology Procedures (DL35000). The Association for Molecular Pathology (AMP) is an international medical and professional association representing approximately 2,400 physicians, doctoral scientists, and medical technologists who perform or are involved with laboratory testing based on knowledge derived from molecular biology, genetics, and genomics. Membership includes professionals from the government, academic medicine, private and hospital-based clinical laboratories, and the in vitro diagnostics industry. As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. Members of both AMP and CAP are experts in molecular pathology and the implementation of this coverage policy will directly impact their practices. We are submitting joint comments because at this time both of our organizations share the same concerns regarding this draft LCD. CPT codes 81120 (IDH1), 81121 (IDH2), 81175 and 81176 (ASXL1), 81334 (RUNX1), 81335 (TPMT), 81479 (MYD88) With regard to these six new CPT category one codes: 81121, 81120, 81175, 81176, 81334, and 81335, and the new MYD88 indication for 81479 we request that NGS consider adding the following statements to the Coverage Guidance (Coverage Indications, Limitations, and/or Medical Necessity) and some additional ICD10 diagnosis codes that Support Medical Necessity to the final policy.
    [Show full text]
  • Fistulization Between Stomach and Transverse Colon Because of Nasogastric Feeding Tube
    LETTER 89 Fistulization between stomach and transverse colon because of nasogastric feeding tube Mustafa Çelik, Ali Kagan Gokakin, Utku Ozgen, Mustafa Gurkan Haytaoglu Pamukkale University, Gastroenterology Department, 20070 Deni̇ zi, Turkey. To The Editor (NSAIDs) or steroids. Neoplasia is another rare cause. Iatrogenic causes such as nasogastric and orogastric tube Nasogastric tube is commonly used for nasogastric misplacements are extremely rare, despite the frequent decompression, feeding, and gastric lavage. In the gastrointestinal tract, malposition, coiling, or knotting can occur anywhere along the course of the tube, including the pharynx, pyriform sinus, esophagus, stomach, and duodenum (1). Nasogastric tubes can cause gastritis or gastric bleeding because of chronic irritation or pressure necrosis (2). Patients with prior esophageal or gastric surgery have a higher risk for gastrointestinal perforation, and those with facial trauma are at a risk for cribriform plate perforation and intracranial insertion (3-4). However, there are no data regarding gastrocolic fistulization secondary to the use of a nasogastric feeding tube. A 21-year-old female patient, being followed up for cerebral palsy, was admitted to the emergency service because of fecaloid emesis and the drainage of fecaloid content from the nasogastric feeding tube for 2 days. The patient had meningitis when she was 3-month-old and had been followed up for cerebral palsy. It was learned that her percutaneous endoscopic gastrostomy catheter was removed approximately 45 days ago because of dysfunction, and feeding was continued via a nasogastric feeding tube. The silicone nasogastric feeding tube was inserted up to 50 cm. There was no complaint until the last 2 days when fecaloid emesis and fecaloid drainage via the nasogastric feeding tube occurred.
    [Show full text]